Structural organization of the human TOP2A and TOP2B genes

Gene

Volumn 221, Issue 2, 1998, Pages 255-266

  Lang, A J ^a   Mirski, S E L ^a   Cummings, H J ^a   Yu, Q ^a   Gerlach, J H ^a   Cole, S P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Drug resistance; Gene duplication; Mutation; Topoisomerase II

Indexed keywords

COMPLEMENTARY DNA; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING);

AMINO ACID SEQUENCE; ARTICLE; CANCER CHEMOTHERAPY; GENE DUPLICATION; GENE MUTATION; GENOME; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; DNA; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; EVOLUTION, MOLECULAR; EXONS; GENES; HUMANS; INTRONS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0032561521     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00468-5     Document Type: Article

References (38)

1. Austin C.A., Marsh K.L. Eukaryotic DNA topoisomerase IIβ BioEssays. 20:1998;215-226.
2. Berget S.M. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:1995;2411-2414.
3. Bugg B.Y., Danks M.K., Beck W.T., Suttle D.P. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide. Proc. Natl. Acad. Sci. USA. 88:1991;7654-7658.
4. Campain J.A., Gottesman M.M., Pastan I. A novel mutant topoisomerase IIα present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429. Biochemistry. 33:1994;11327-11332.
5. Capranico G., Tinelli S., Austin C.A., Fisher M.L., Zunino F. Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochim. Biophys. Acta. 1132:1992;43-48.
6. Chung T.D.Y., Drake F.H., Tan K.B., Per S.R., Crooke S.T., Mirabelli C.K. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc. Natl. Acad. Sci. USA. 86:1989;9431-9435.
7. r 170 000 isozyme of DNA topoisomerase II in human tumor cells. Cancer Res. 53:1993;1373-1379.
8. Davies S.L., Jenkins J.R., Hickson I.D. Human cells express two differentially spliced forms of topoisomerase IIβ mRNA. Nucleic Acids Res. 21:1993;3719-3723.
9. Dooley T.P., Huang Z. Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16. Biochem. Biophys. Res. Commun. 228:1996;134-140.
10. Feldhoff P.W., Mirski S.E.L., Cole S.P.C., Sullivan D.M.M. Altered subcellular distribution of topoisomerase IIα in a drug resistant human small cell lung cancer cell line. Cancer Res. 54:1994;756-762.
11. Harker W.G., Slade D.L., Parr R.L., Holguin M.H. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase IIα messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone. Cancer Res. 55:1995;4962-4971.
12. Hawkins J.D. A survey on intron and exon lengths. Nucleic Acids Res. 16:1988;9893-9905.
13. Hinds M., Deisseroth K., Mayes J., Altschuler E., Jansen R., Ledley F.D., Zwelling L.A. Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. Cancer Res. 51:1991;4729-4731.
14. Hochhauser D., Stanway C.A., Harris A.L., Hickson I.D. Cloning and characterization of the 5′-flanking region of the human topoisomerase IIα gene. J. Biol. Chem. 267:1992;18961-18965.
15. Hsuing Y., Jannatipour M., Rose A., McMahon J., Duncan D., Nitiss J.L. Functional expression of human topoisomerase IIα in yeast: mutations at amino acids 450 or 803 of topoisomerase IIα result in enzymes that can confer resistance to anti-topoisomerase II agents. Cancer Res. 56:1996;91-99.
16. Jenkins J.R., Ayton P., Jones T., Davies S.L., Simmons D.L., Harris A.L., Sheer D., Hickson I.D. Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res. 20:1992;5587-5592.
17. Kingsmore S.F., Tang C.M., Lo C.-K., Hwang J., Seldin M.F. Genetic mapping of the mouse topoisomerase II alpha gene to chromosome 11. Mamm. Genome. 4:1993;288-289.
18. Kohno K., Danks M.K., Matsuda T., Nitiss J.L., Kuwano M., Beck W.T. A novel mutation of DNA topoisomerase IIα gene in an etoposide-resistant human cancer cell line. Cell. Pharmacol. 2:1995;87-90.
19. Kubo A., Yoshikawa A., Hirashima T., Masuda N., Takada M., Takahara J., Fukuoka M., Nakagawa K. Point mutations of the topoisomerase IIα gene in patients with small cell lung cancer treated with etoposide. Cancer Res. 56:1996;1232-1236.
20. Lee M.-S., Wang J.C., Beran M. Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of topoisomerase II. J. Mol. Biol. 223:1992;837-843.
21. Lincke C.R., Smit J.J.M., Van der Velde-Koerts T., Borst P. Structure of the MDR3 gene and physical mapping of the human MDR locus. J. Biol. Chem. 266:1991;5303-5310.
22. Lynn R., Giaever G., Swanberg S.L., Wang J.C. Tandem regions of yeast DNA topoisomerase II share homology with different subunits of bacterial gyrase. Science. 233:1986;647-649.
23. Matsumoto Y., Takano H., Fojo T. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype. Cancer Res. 57:1997;5086-5092.
24. Meyer K.N., Kjeldsen E., Straub T., Knudsen B.R., Hickson I.D., Kikuchi A., Kreipe H., Boege F. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136:1997;775-788.
25. r 160 000 topoisomerase IIα is associated with the loss of putative bipartite nuclear localization signals in a drug resistant human lung cancer cell line. Cancer Res. 55:1995;2129-2134.
26. Mirski, S.E.L., Cole, S.P.C., 1997. Multidrug resistance in small cell lung cancer. In: Bernal, S.D. (Ed.), Drug Resistance in Oncology. Marcel Dekker, New York, pp. 27-75.
27. Mirski S.E.L., Evans C.D., Almquist K.C., Slovak M.L., Cole S.P.C. Altered topoisomerase IIα in a drug-resistant small cell lung cancer cell line selected in VP-16. Cancer Res. 53:1993;4866-4873.
28. Mirski S.E.L., Gerlach J.H., Cummings H.J., Zirngibl R., Greer P.A., Cole S.P.C. Bipartite nuclear localization signals in the C-terminus of human topoisomerase IIα Exp. Cell Res. 237:1997;452-455.
29. Ng S.-w., Liu Y., Schnipper L.E. Cloning and characterization of the 5′-flanking sequence for the human DNA topoisomerase II beta gene. Gene. 203:1997;113-119.
30. Patel S., Fisher L.M. Novel selection and genetic characterisation of an etoposide-resistant human leukaemic CCRF-CEM cell line. Br. J. Cancer. 67:1993;456-463.
31. Roca J. The mechanisms of DNA topoisomerases. Trends Biochem. Sci. 20:1995;156-160.
32. Saitou N., Nei M. The neighbour-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:1987;406-425.
33. Shapiro M.B., Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15:1987;7155-7174.
34. Shiozaki K., Yanagida M. A functional 125-kDa core polypeptide of fission yeast DNA topoisomerase II. Mol. Cell Biol. 11:1991;6093-6102.
35. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The Clustal X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:1997;4876-4882.
36. Tsai-Pflugfelder M., Liu L.F., Liu A.A., Tewey K.M., Whang-Peng J., Knutsen T., Huebner K., Croce C.M., Wang J.C. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc. Natl. Acad. Sci. USA. 85:1988;7177-7181.
37. 1492 in the COOH-terminal region of topoisomerase IIα in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization Cancer Res. 57:1997;4451-4454.
38. Yu Q., Mirski S.E.L., Sparks K.E., Cole S.P.C. Two COOH-terminal truncated cytoplasmic mutant forms of topoisomerase IIα in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing. Biochemistry. 36:1997;5868-5877.